|Last Price$124.88||Day Change (%)0.75%|
|Open Price$124.42||Day Change ($)0.93|
|Day Range123.09–125.99||52-Week Range51.93–132.99|
As of Thu 5/21/2015 5:00:00 PM | USD
Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)
BioMed Realty Trust Reports First Quarter 2015 Financial Results
Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.